Back to search

Article

The utility of homologous recombination deficiency biomarkers across cancer types

2021-02-20

Abstract excerpt

<h4>Background</h4> Genomic alterations in BRCA1/2 and genomic scar signatures are associated with homologous recombination DNA repair deficiency (HRD) and serve as therapeutic biomarkers for platinum and PARP inhibitors in breast and ovarian cancers. However, the clinical significance of these biomarkers in other homologous recombination repair-related genes or other cancer types is not fully understood. <h4>Resu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
389ccddb-703f-5ae8-ac24-80984167b8f6
DOI
10.1101/2021.02.18.21251882
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The utility of homologous recombination deficiency biomarkers across cancer typesDOI 10.1101/2021.02.18.21251882
Select a neighboring publication to make it the new centre.